Andrew J. Stewart Coats Monash University, Australia
& University of Warwick, UK

09:10-09:30, 25 September (GMT AM 12:10-12:30)

[IJHF Special Session]

What a Journal Editor Is Really Looking for

11:30-11:45, 26 September (GMT AM 02:30-02:45)

 Where Is the Correct Position of ARNI in HF?

ARNI in Acute Decompensated HF

Carolyn Lam Duke-NUS Medical School,
Singapore

11:45-12:00, 26 September (GMT AM 02:45-03:00)

 Where Is the Correct Position of ARNI in HF?

ARNI in HFpEF

Chanchal Chandramouli National Heart Centre Singapore,
Singapore

09:00-09:15, 26 September (GMT AM 12:00-12:15)

 HF; Are Women Different?

Sex Differences in Heart Failure: The Mars vs. Venus Story

Christoph Maack University Clinic Würzburg,
Germany

12:05-12:30, 25 September (GMT AM 03:05-03:30)

[Scientific Session – Servier]

How to Keep the HF Patients Out of the Hospital with Ivabradine

15:45-16:00, 25 September (GMT 06:45-07:00)

 SNS and HF

New Perspective beyond SNS, Other Way to Go

David Sim National Heart Centre Singapore,
Singapore

13:55-14:10, 26 September (GMT AM 04:55-05:10)

Mechanical Circulatory Support

Performance Measures for MCS Program in National Heart Centre Singapore

Erland Erdmann University of Cologne,
Germany

12:20-12:50, 26 September (GMT AM 03:20-03:50)

[Scientific Session - Merck & Daewoong]

Treatment of CHF with Beta-blockers

Gerasimos Filippatos National and Kapodistrian University
of Athens, Greece

13:00-13:15, 25 September (GMT AM 04:00-04:15)

 Cardiometabolic Disorders in HF (I)

HF and Diabetes: What Is the Goal of Treatment?

9:30-9:45, 26 September (GMT AM 12:30-12:45)

 Cardiometabolic Disorders in HF (II)

Understanding the Mechanism of SGLT2 Inhibition in HF and Diabetes

12:20-12:50, 26 September (GMT AM 03:20-03:50)

[Scientific Session – Boehringer Ingelheim & Lilly]

Heart Failure, Further Risk Management for the Patient with Type 2 Diabetes

Giuseppe Rosano University of Catanzaro, Italy
& St George’s University, UK

16:55-17:10, 25 September (GMT 07:55-08:10)

 [Joint Session with HFA]
Patient Reported Outcome (PRO) Research in HF

Pitfalls of PRO Measurements: How to Overcome?

09:00-09:15, 26 September (GMT AM 00:00-00:15)

 Cardiometabolic Disorders in HF (II)

Diabetes and Cardiovascular Risk: Focus on HF

Jian Zhang Fuwai Hospital,
China

10:30-10:45, 27 September (GMT AM 01:30-01:45)

 [Joint Session with CHFA]
HF Epidemiology

HF Pandemic in Asia

Jignesh K. Patel Cedars-Sinai Smidt Heart Institute,
USA

11:45-12:00, 26 September (GMT AM 02:45-03:00)

 Cardiac Amyloidosis

Recent Advances with Emphasis on ATTR

Kiran Kaur Khush Stanford University,
USA

15:40-15:55, 26 September (GMT AM 06:40-06:55)

 [Joint Session with ISHLT]
Controversies and Advances in Heart Transplantation

Decreasing Waitlist Mortality: Expanded Donors and Prioritized Candidates

Koichiro Kinugawa University of Toyama,
Japan

09:00-09:15, 27 September (GMT AM 12:00-12:15)

 [Joint Session with JHFS]
How to Establish a Good LVAD Program

Patient Selection for LVAD: Who Is the Good Candidate?

Mandeep R. Mehra Brigham and Women's Hospital,
USA

15:10-15:25, 26 September (GMT AM 06:10-06:25)

 [Joint Session with ISHLT]
Controversies and Advances in Heart Transplantation

Expanding Donor Organ Recovery: A Global Perspective

Michael Böhm University of the Saarland in Homburg/Saar,
Germany

11:15-11:30, 26 September (GMT AM 02:15-02:30)

 Where Is the Correct Position of ARNI in HF?

ARNI in VHD (Reverse Remodeling)

Minoru Ono University of Tokyo Hospital,
Japan

09:30-09:45, 27 September (GMT AM 12:30-12:45)

 [Joint Session with JHFS]
How to Establish a Good LVAD Program

Medical Pitfalls in Post-LVAD Care

Murray Esler Baker Heart and Diabetes Institute,
Australia

15:15-15:30, 25 September (GMT AM 06:15-06:30)

 SNS and HF

Medications for SNS in HF

Petar M. Seferović Belgrade University,
Serbia

16:25-16:40, 25 September (GMT AM 07:25-07:40)

 [Joint Session with HFA]
Patient Reported Outcome (PRO) Research in HF

What is PRO and How Can We Utilize It in HF Research?

Yusuhiko Sakata Tohoku University,
Japan

13:15-13:30, 25 September (GMT AM 04:15-04:30)

 Dx and Tx of HFpEF

Diagnostic Values and Prognostic Impact of Temporal LV Structures Changes in HFpEF

Yuhui Zhang Fuwai Hospital,
China

11:00-11:15, 27 September (GMT AM 02:00-09:15)

 [Joint Session with CHFA]
HF Epidemiology

DM and HF